X-155228416-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_003372.7(VBP1):c.318G>T(p.Leu106Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 22)
Consequence
VBP1
NM_003372.7 missense
NM_003372.7 missense
Scores
1
6
9
Clinical Significance
Conservation
PhyloP100: 0.922
Genes affected
VBP1 (HGNC:12662): (VHL binding protein 1) The protein encoded by this gene interacts with the Von Hippel-Lindau protein to form an intracellular complex. The encoded protein functions as a chaperone protein, and may play a role in the transport of the Von Hippel-Lindau protein from the perinuclear granules to the nucleus or cytoplasm. Alternative splicing and the use of alternate transcription start sites results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VBP1 | NM_003372.7 | c.318G>T | p.Leu106Phe | missense_variant | 4/6 | ENST00000286428.7 | NP_003363.1 | |
VBP1 | NM_001303543.1 | c.426G>T | p.Leu142Phe | missense_variant | 4/6 | NP_001290472.1 | ||
VBP1 | NM_001303544.1 | c.303G>T | p.Leu101Phe | missense_variant | 5/7 | NP_001290473.1 | ||
VBP1 | NM_001303545.1 | c.207G>T | p.Leu69Phe | missense_variant | 4/6 | NP_001290474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VBP1 | ENST00000286428.7 | c.318G>T | p.Leu106Phe | missense_variant | 4/6 | 1 | NM_003372.7 | ENSP00000286428 | P1 | |
VBP1 | ENST00000535916.5 | c.303G>T | p.Leu101Phe | missense_variant | 5/7 | 2 | ENSP00000438694 | |||
VBP1 | ENST00000625964.2 | c.303G>T | p.Leu101Phe | missense_variant | 4/6 | 5 | ENSP00000486053 | |||
VBP1 | ENST00000460509.1 | n.191G>T | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.318G>T (p.L106F) alteration is located in exon 4 (coding exon 4) of the VBP1 gene. This alteration results from a G to T substitution at nucleotide position 318, causing the leucine (L) at amino acid position 106 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Vest4
MutPred
0.56
.;.;Gain of catalytic residue at L106 (P = 0.003);
MVP
MPC
1.9
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.